恢复性神经刺激治疗慢性机械性下背痛的5年纵向随访
这项前瞻性、开放标签、上市后临床随访研究在五个英国中心纳入42例慢性机械性下背痛患者,采用植入式ReActiv8系统进行恢复性神经刺激,随访5年。结果显示疼痛、功能障碍和生活质量均获得显著且持久的改善,82%患者达到疼痛或功能障碍的最小临床重要改善,62%患者疼痛缓解(NRS≤3)。
要点
- 5年随访中,疼痛NRS均值从7.0降至3.2,ODI从46.6降至26.1,EQ-5D指数从0.426升至0.703。
- 82%患者达到疼痛或功能障碍的最小临床重要改善,62%患者疼痛缓解(NRS≤3)。
- 设备5年平均使用1106小时,使用量随时间下降,较低使用量与无应答相关但无法确定因果关系。
核心结论
- 恢复性神经刺激可为伴多裂肌功能障碍的慢性机械性下背痛患者提供疼痛、功能和生活质量的稳健且持续改善,支持其长期有效性和安全性。
研究设计与样本
- 前瞻性、开放标签、上市后临床随访研究,在五个英国中心纳入42例慢性机械性下背痛患者,植入ReActiv8系统进行恢复性神经刺激,随访5年。
主要发现
- 5年时34/42例(81%)完成随访,疼痛NRS均值从7.0降至3.2,ODI均值从46.6降至26.1,EQ-5D指数从0.426升至0.703。
- 82%患者达到疼痛或功能障碍的最小临床重要改善,62%患者疼痛缓解(NRS≤3)。
- 设备5年平均使用1106小时,使用量随时间下降;较低使用量与无应答相关,但无法确定因果关系。
临床怎么用
- 对于伴多裂肌功能障碍的慢性机械性下背痛患者,恢复性神经刺激可作为靶向多裂肌功能障碍的长期治疗选择。
局限性
- 本研究为开放标签、非对照设计,样本量较小(42例),且设备使用与应答的关联不能确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic mechanical low back pain (CLBP) often stems from dysfunction of the multifidus muscle, leading to impaired motor control and pain. Restorative neurostimulation has emerged as a novel treatment targeting this dysfunction by delivering electrical stimulation to the medial branches of the L2 dorsal rami to restore multifidus activation. METHODS: This prospective, open-label, postmarket clinical follow-up study aimed to evaluate 5-year clinical outcomes and device utilization trends in a cohort of 42 patients with CLBP treated across five UK sites with restorative neurostimulation via an implanted ReActiv8 neurostimulation system. Patients were followed for 5 years, with assessments of pain (Numerical Rating Scale (NRS)), disability (Oswestry Disability Index (ODI)), and health-related quality of life (EuroQol-5 Dimension, 5 Level (EQ-5D-5L)) at baseline and regular intervals. Therapy utilization was collected via implantable device logs. RESULTS: At 5 years, 34/42 patients (81%) completed follow-up. Significant and durable improvements were observed in pain (mean NRS reduced from 7.0 to 3.2), disability (mean ODI reduced from 46.6 to 26.1), and quality of life (EQ-5D index increased from 0.426 to 0.703). A total of 82% of patients achieved a minimally clinically important change in either pain or disability, and 62% were pain remitters (NRS ≤3). Device usage averaged 1106 hours over 5 years, with reductions in usage over time. Lower usage was associated with non-response, though causality could not be determined. CONCLUSIONS: Restorative neurostimulation provides robust, sustained improvements in pain, function, and quality of life in patients with CLBP associated with multifidus dysfunction. These results support its long-term efficacy and safety in real-world clinical practice. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Identifier: NCT01985230.
引用
- Thomson S, Williams A, Vajramani G, et al. 5-year longitudinal follow-up of patients treated for chronic mechanical low back pain using restorative neurostimulation. Reg Anesth Pain Med. 2025. PMID: 40813075. doi:10.1136/rapm-2025-106899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。